Advertisement
Hoth Therapeutics Partners Altasciences For Study On HT-KIT Cancer Treatment
(RTTNews) - Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday that it has completed bioanalytical method development under its prior agreement with Altasciences.
The company now plans to further engage Altasciences to perform a key study of mouse blood and plasma analysis from samples collected in Hoth's sponsored scientific research conducted at NC State University.
The blood and plasma samples collected are part of a dose response study in a humanized mouse model.
The upcoming study will use the newly validated bioanalytical method developed at Altasciences to test the amount of HT-KIT from the dose response study and help determine how long HT-KIT remains in the blood stream post dosing.
read more
Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA
Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday it has submitted a request for a Pre-Investigational New Drug (IND) meeting to the U.S. Food and Drug Administration (FDA) to discuss the proposed drug development program for HT-KIT, a new molecular entity, for the treatment of advance systemic mastocytosis (AdvSM), a rare aggressive form of cancer.
RTTNews
|
665 days ago
Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders
Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Thursday that the U.S. Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application for the company's HT-001 therapeutic for the treatment for rash and skin disorders associated with epidermal growth factor receptor (EGFR) inhibitor therapy.
RTTNews
|
921 days ago
Hoth Therapeutics Partners Altasciences For Manufacturing HT-TBI For Traumatic Brain Injury/Stroke
Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Tuesday that it has signed an agreement with Altasciences, a fully integrated early phase CRO/CDMO, to develop and manufacture the HT-TBI drug product formulation.
RTTNews
|
1021 days ago
Swiss Market Slumps On Monday
The Swiss stock market extended its losing streak to three sessions on Monday, shedding almost 40 points or 0.3 percent since the middle of last week.
RTTNews
|
2h 8min ago
European Markets Close Mixed On Monday
The major European markets closed mixed on Monday, mired in uncertainty over U.S. trade policies after the Trump administration indicated the deadline for imposing new tariffs on U.S. trade partners has been extended until August 1st.
RTTNews
|
2h 18min ago
Tesla Shares Hit By Elon Musk's Plan To Form New Political Party
Tesla Inc. shares were losing around 8% in the morning trading on the Nasdaq on Monday after CEO Elon Musk announced his plans to launch a new U.S. political party following his ongoing feud with President Donald Trump over the 'One Big, Beautiful Bill.' Tesla founder and the former head of the Department of Government Efficiency or DOGE, launched the 'America Party' on Saturday in the latest...
RTTNews
|
3h 49min ago
FTSE 100 Trades Below The Flatline
Persisting tensions on the trade front and growing concerns over U.K.'s fiscal outlook dampened sentiment and dragged down the FTSE 100 to negative territory.
RTTNews
|
5h 52min ago
Domino's Pizza's Online $9.99 Offer Of Any Pizza With Any Toppings On July 7- Aug. 3
Domino's Pizza Inc., the largest pizza company in the world, announced its "Best Deal Ever' promotion, offering any pizza with any toppings for $9.99 each when they order online between July 7 and August 3. Domino's $9.99 deal includes Hand Tossed, Handmade Pan, New York Style, Gluten Free and Crunchy Thin Crust, as well as an assortment of sauces and toppings.
RTTNews
|
5h 57min ago
